Smith & Nephew PLC
ISIN: GB0009223206 | Ticker: NPWA | LEI: 213800ZTMDN8S67S1H61
Country: United Kingdom
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Physical health is never just about our body. It’s our mind, feelings and ambitions. When something holds it back, it’s our whole life on hold.
We’re here to change that, to use technology to take the limits off living, and help other medical professionals do the same.
So that farmworkers, rugby players, grandmas and their grandkids stare down fear, see that anything’s possible, then go on stronger. Inspired by a simple promise. Two words that bring together all we do.
1856
Served areaWorldwide
Headcount17,500
HeadquartersBuilding 5, Croxley Park, Hatters Lane, WD18 8YE Watford – United Kingdom
| Line item in (usd) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | N/A | 11,012,000,000.00 | 10,920,000,000.00 | 9,966,000,000.00 |
| Noncurrent Assets | N/A | N/A | 6,348,000,000.00 | 6,496,000,000.00 | 6,110,000,000.00 |
| Property Plant And Equipment | N/A | N/A | 1,449,000,000.00 | 1,513,000,000.00 | 1,455,000,000.00 |
| Goodwill | N/A | N/A | 2,928,000,000.00 | 2,989,000,000.00 | 3,031,000,000.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | 1,486,000,000.00 | 1,398,000,000.00 | 1,236,000,000.00 |
| Investments In Associates Accounted For Using Equity Method | N/A | N/A | 108,000,000.00 | 188,000,000.00 | 46,000,000.00 |
| Other Noncurrent Receivables | N/A | N/A | 33,000,000.00 | 15,000,000.00 | 12,000,000.00 |
| Deferred Tax Assets | N/A | N/A | 202,000,000.00 | 201,000,000.00 | 177,000,000.00 |
| Noncurrent Financial Assets Availableforsale | N/A | N/A | 9,000,000.00 | 10,000,000.00 | 12,000,000.00 |
| Noncurrent Recognised Assets Defined Benefit Plan | N/A | N/A | 133,000,000.00 | 182,000,000.00 | 141,000,000.00 |
| Current Assets | N/A | N/A | 4,664,000,000.00 | 4,424,000,000.00 | 3,856,000,000.00 |
| Inventories | N/A | N/A | 1,691,000,000.00 | 1,844,000,000.00 | 2,205,000,000.00 |
| Trade And Other Current Receivables | N/A | N/A | 1,116,000,000.00 | 1,184,000,000.00 | 1,264,000,000.00 |
| Current Receivables From Taxes Other Than Income Tax | N/A | N/A | 95,000,000.00 | 106,000,000.00 | 37,000,000.00 |
| Cash and cash equivalents | 333,000,000.00 | 257,000,000.00 | 1,751,000,000.00 | 1,285,000,000.00 | 344,000,000.00 |
| Balances With Banks | N/A | N/A | 1,762,000,000.00 | 1,290,000,000.00 | 350,000,000.00 |
| Equity And Liabilities | N/A | N/A | 11,012,000,000.00 | 10,920,000,000.00 | 9,966,000,000.00 |
| Equity | 4,874,000,000.00 | 5,141,000,000.00 | 5,279,000,000.00 | 5,568,000,000.00 | 5,259,000,000.00 |
| Issued Capital | N/A | N/A | 177,000,000.00 | 177,000,000.00 | 175,000,000.00 |
| Retained Earnings | N/A | N/A | 4,958,000,000.00 | 5,225,000,000.00 | 5,026,000,000.00 |
| Share Premium | N/A | N/A | 612,000,000.00 | 614,000,000.00 | 615,000,000.00 |
| Treasury Shares | N/A | N/A | 157,000,000.00 | 120,000,000.00 | 118,000,000.00 |
| Capital Redemption Reserve | N/A | N/A | 18,000,000.00 | 18,000,000.00 | 20,000,000.00 |
| Capital Reserve | N/A | 2,266,000,000.00 | 2,266,000,000.00 | 2,266,000,000.00 | 2,266,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | N/A | 5,279,000,000.00 | 5,568,000,000.00 | 5,259,000,000.00 |
| Liabilities | N/A | N/A | 5,733,000,000.00 | 5,352,000,000.00 | 4,707,000,000.00 |
| Noncurrent Liabilities | N/A | N/A | 4,045,000,000.00 | 3,221,000,000.00 | 2,992,000,000.00 |
| Noncurrent Provisions | N/A | N/A | 294,000,000.00 | 35,000,000.00 | 84,000,000.00 |
| Other Noncurrent Payables | N/A | N/A | 94,000,000.00 | 67,000,000.00 | 90,000,000.00 |
| Deferred Tax Liabilities | N/A | N/A | 141,000,000.00 | 144,000,000.00 | 36,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | N/A | 163,000,000.00 | 127,000,000.00 | 70,000,000.00 |
| Current Liabilities | N/A | N/A | 1,688,000,000.00 | 2,131,000,000.00 | 1,715,000,000.00 |
| Current Provisions | N/A | N/A | 123,000,000.00 | 322,000,000.00 | 243,000,000.00 |
| Trade And Other Current Payables | N/A | N/A | 1,022,000,000.00 | 1,096,000,000.00 | 1,098,000,000.00 |
| Current Tax Liabilities Current | N/A | N/A | 206,000,000.00 | 222,000,000.00 | 214,000,000.00 |
| Line item in (usd) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue From Contracts With Customers | 5,138,000,000.00 | 4,560,000,000.00 | 5,212,000,000.00 | 5,215,000,000.00 |
| Profit Loss From Operating Activities | 815,000,000.00 | 295,000,000.00 | 593,000,000.00 | 450,000,000.00 |
| Finance Income | 10,000,000.00 | 6,000,000.00 | 6,000,000.00 | 14,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 1,000,000.00 | 14,000,000.00 | 9,000,000.00 | -141,000,000.00 |
| Profit Loss Before Tax | 743,000,000.00 | 246,000,000.00 | 586,000,000.00 | 235,000,000.00 |
| Income Tax Expense Continuing Operations | 143,000,000.00 | -202,000,000.00 | 62,000,000.00 | 12,000,000.00 |
| Profit (loss) | 600,000,000.00 | 448,000,000.00 | 524,000,000.00 | 223,000,000.00 |
| Line item in (usd) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | N/A | 600,000,000.00 | 448,000,000.00 | 524,000,000.00 | 223,000,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -204,000,000.00 | -45,000,000.00 | -151,000,000.00 | -407,000,000.00 |
| Adjustments For Sharebased Payments | N/A | 32,000,000.00 | 26,000,000.00 | 41,000,000.00 | 40,000,000.00 |
| Adjustments For Undistributed Profits Of Associates | N/A | 1,000,000.00 | 14,000,000.00 | 9,000,000.00 | -141,000,000.00 |
| Cash Flows From Used In Operations | N/A | 1,370,000,000.00 | 972,000,000.00 | 1,048,000,000.00 | 581,000,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 56,000,000.00 | 61,000,000.00 | 80,000,000.00 | 73,000,000.00 |
| Interest Received Classified As Operating Activities | N/A | 4,000,000.00 | 2,000,000.00 | 6,000,000.00 | 7,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | N/A | -22,000,000.00 | N/A | N/A |
| Cash Flows From Used In Operating Activities | N/A | 1,168,000,000.00 | 935,000,000.00 | 877,000,000.00 | 468,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 869,000,000.00 | 170,000,000.00 | 285,000,000.00 | 113,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -1,251,000,000.00 | -606,000,000.00 | -691,000,000.00 | -472,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 63,000,000.00 | 16,000,000.00 | 0.00 | 158,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 7,000,000.00 | 1,164,000,000.00 | -645,000,000.00 | -926,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -76,000,000.00 | 1,493,000,000.00 | -459,000,000.00 | -930,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 0.00 | 1,000,000.00 | -7,000,000.00 | -11,000,000.00 |
| Cash and cash equivalents | 333,000,000.00 | 257,000,000.00 | 1,751,000,000.00 | 1,285,000,000.00 | 344,000,000.00 |
Please note that some sums might not add up.
| Position Holder | Short Interest in Percent | Date |
|---|---|---|
| Citadel Advisors LLC | 0.59% | 18.10.23 |
| Citadel Advisors LLC | 0.57% | 03.08.23 |
| Citadel Advisors LLC | 0.58% | 14.09.23 |
| Citadel Advisors LLC | 0.69% | 12.10.23 |
| Citadel Advisors LLC | 0.60% | 01.09.23 |
| Citadel Advisors LLC | 0.67% | 28.09.23 |
| Total | 3.70% |
GB0009223206
LEI213800ZTMDN8S67S1H61
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryFTSE 100
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.